195. Inflammation and End Organ Disease: From the Bench to the Bedside
Saturday, October 10, 2015: 8:30 AM-10:00 AM
Room: 28--ABCDE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • recognize the role of inflammation as a cause of disease in HIV-infected patients and upcoming treatment advances that may improve patient care
  • summarize advances in our understanding of the microbiome in HIV-infected patients and how that research may affect treatment HIV
  • evaluate causes of cardiovascular disease and options for prevention of cardiovascular disease in HIV-infected patients

Target Audience: Researchers, Members-in-training, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Clinicians, Academicians

Tracks: HIV-STD-TB, Adult ID, Trainee

Moderators:  Rajesh Gandhi, MD, FIDSA, Massachusetts General Hospital and Ragon Institute and Ighovwerha Ofotokun, MD, MSc, FIDSA, Emory University School of Medicine

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-192-L01-P


R. Gandhi, Gilead: Recipient of educational grant , Educational grant
EBSCO: Educational grant recipient , Educational grant
Roche: Educational grant recipient , Educational grant

I. Ofotokun, Bristol-Myers Squibb: Grant Investigator , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.